Table 4.
Costa of recommended and non recommended medical procedures performed during the surveillance period (n=385)
| Procedures | Observed total cost (€) | Relative cost of medical procedures |
|---|---|---|
| Recommended procedures | ||
| Clinical examination | 92,878 | 39% |
| General Practitioner | 36,620 | 35% |
| Specialistb | 56 258 | 65% |
| Abdominal ultrasound | 91,382 | 39% |
| Chest X-ray | 14,939 | 6% |
| Colonoscopy | 36,778 | 16% |
| Total cost of recommended procedures | 235,976 | 86% |
| Non recommended procedures | ||
| CT scans | 10,709 | 17% |
| MRI | 918 | 1% |
| Scintigraphy | 773 | 1% |
| Endorectal ultrasound | 1,930 | 3% |
| Carcinoembryonic antigen (CEA) | 16,348 | 25% |
| Cancer antigen 19-9 (CA19-9) | 7,768 | 12% |
| Total cost of non recommended procedures | 38,445 | 14% |
| Total surveillance cost | 274,421 | |
| Average surveillance cost per patient | 713 | |
a
Reimbursement prices were used as a proxy of costs
b
Specialist included gastroenterologists, oncologists, surgeons and other specialists